CJCP
  中文版
  English Version
 
CJCP  2018, Vol. 20 Issue (4): 290-294    DOI: 10.7499/j.issn.1008-8830.2018.04.007
CLINICAL RESEARCH Current Issue| Next Issue| Archive| Adv Search  | 
BRAF-V600E mutation and its clinical significance in children with Langerhans cell histiocytosis
TANG Xue1, GUO Xia1, SUN Lin-Yong2, AI Yuan1, YANG Xue1, SUN Jing-Jing1, WU Jian-Rong1, GAO Ju1
Department of Pediatrics, West China Second University Hospital, Sichuan University/Key Laboratory of Birth Defects and Related Diseases of Women and Children
Download: PDF (1181 KB)   HTML(215)
Export: BibTeX | EndNote (RIS)      Supporting Info
Abstract  Objective To investigate the clinical significance of BRAF-V600E mutation in children with Langerhans cell histiocytosis (LCH). Methods Real-time fluorescence quantitative PCR was used to detect BRAF-V600E mutation in paraffin-embedded tissue samples from 26 children with LCH. A retrospective analysis was performed for the association of BRAF-V600E mutation with clinical features and prognosis of children with LCH. Results Of the 26 children, 25 received standard chemotherapy, with a 2-year overall survival (OS) rate of 100% and a 2-year event-free survival (EFS) rate of 88%. Of the 26 pathological samples, 18 (70%) came from bone tissue, and the positive rate of BRAF-V600E mutation reached 50% (13/26). The positive rate of BRAF-V600E gene mutation was not associated with age, sex, affected organ, clinical classification, early treatment response, recurrence, and 2-year OS and EFS rates of the children with LCH (P > 0.05), but it was associated with clinical grouping of LCH (P < 0.05). Conclusions Children with LCH tend to have a high OS rate and a high incidence rate of BRAF-V600E mutation. BRAF-V600E mutation is associated with clinical grouping of LCH.
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
TANG Xue
GUO Xia
SUN Lin-Yong
AI Yuan
YANG Xue
SUN Jing-Jing
WU Jian-Rong
GAO Ju
Key wordsLangerhans cell histiocytosis      BRAF-V600E mutation      Real-time fluorescence quantitative PCR      Child     
Received: 25 December 2017     
Corresponding Authors: 高举,男,主任医师,教授。Email:gaoju651220@126.com     E-mail: gaoju651220@126.com
Cite this article:   
TANG Xue,GUO Xia,SUN Lin-Yong et al. BRAF-V600E mutation and its clinical significance in children with Langerhans cell histiocytosis[J]. CJCP, 2018, 20(4): 290-294.
TANG Xue,GUO Xia,SUN Lin-Yong et al. BRAF-V600E mutation and its clinical significance in children with Langerhans cell histiocytosis[J]. CJCP, 2018, 20(4): 290-294.
URL:  
http://www.zgddek.com/EN/10.7499/j.issn.1008-8830.2018.04.007     OR     http://www.zgddek.com/EN/Y2018/V20/I4/290
Copyright © 2004-2005 Chinese Journal Of Contemporary Pediatrics All rights reserved.
Addr: 87 Xiangya Road, Changsha, Hunan, 410008, PRC
Tel: 0731-84327402 Fax: 0731-84327922 E-mail: cjcp1999@csu.edu.cn